Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the central nervous system (CNS). The Company’s marketed product, Zanaflex Capsules, is approved by the United States Food and Drug Administration (FDA) for the management of spasticity. The Company’s product candidate Fampridine-SR, has completed two positive Phase III clinical trials for the improvement of walking ability in patients with MS. The research and development programs for the Company include Remyelination Programs and Chondroitinase Program.

Contact Details

Office Address

Acorda Therapeutics, Inc.
15 Skyline Drive
Hawthorne, NY, USA 10532
Phone: (914) 347-4300
Fax: (914) 347-4560


President CEO, and Director

Ron Cohen


David Lawrence

Business Reviews for Acorda Therapeutics, Inc.

Related Companies